Su1321 - Efficacy and Feasibility of Secondaly Prophylactic Pegfilgrastim in Patients with Pancreatic Cancer Recieving Modified Folfirinox: A Single Center Retrospective Study — Kentaro Yamao (2018) | RDL Network
Su1321 - Efficacy and Feasibility of Secondaly Prophylactic Pegfilgrastim in Patients with Pancreatic Cancer Recieving Modified Folfirinox: A Single Center Retrospective Study
Discussion(0)
No comments yet. Be the first to comment.